Skip to main content
Clinical Trials/JPRN-UMIN000044148
JPRN-UMIN000044148
Completed
未知

Examination of simple intervention using genetic polymorphism information for excessive drinking - Examination of intervention using genetic polymorphism information for excessive drinking

niversity of Tsukuba, Faculty of medicine0 sites200 target enrollmentJune 1, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Tsukuba, Faculty of medicine
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2021
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Tsukuba, Faculty of medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Those who do not want to know the result of the alcohol constitution test 2\. Those who have difficulty communicating in Japanese

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Piolt study of usefulness of analysis of genetic polymorphism of aldehyde dehydrogenase 2 (ALDH2) in safety of paclitaxel for the patients with alcohol intoleranceBreast cancer, gastric cancer, ovarian cancer, non-small cell lung cancer, head and neck cancer, esophageal cancer
JPRN-UMIN000007624Osaka International Cancer Institute20
Recruiting
Phase 2
Examination of the usefulness of the genetic test of Circulating tumor cells (CTCs) in patients with gastrointestinal cancer (Circle-1, Circle-2 Trial)clinical stage IV gastrointestinal cancer
JPRN-UMIN000014095ational Cancer Center80
Recruiting
Not Applicable
Evaluation of the effect of the genetic polymorphism of drug metabolizing enzyme/transporter and drug interaction on the pharmacokinetics and pharmacodynamics of clopidogrelNot Applicable
KCT0000429Seoul National University18
Recruiting
Not Applicable
Evaluation Study for its Clinical Utility of Gene Prognostic Signature MammaPrint for Early-Breast CancerBreast Cancer
JPRN-UMIN000002834Department of Breast and Endocrine Surjery, Juntendo University School of Medicine50
Active, not recruiting
Phase 1
Treatment of solid tumors with genetically modified patients' own T-cells recognizing a particular tumor markerRecurrent and / or refractory solid tumorsMedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2019-002370-31-DEImmatics US InC476